Zefia Uppal

Bachelor of Medicine and Bachelor of Science,  Massachusetts General Hospital 

Location: Africa

Consulting Services

Admin and Customer Support Research Consulting Pharma-CRO-Device Case Consulting Journal Manuscript

Areas Of Interest

CYP450 4-Hydroxylase Excitatory Amino Acid Transporter 3 Adrenergic beta-1 Receptor Blockers Estradiol Receptor alpha Ruthenium Radioisotopes Dihydroxyacetone 3 Phosphate Mediators, Lymphocyte Madurella grisea Cortex, Secondary Olfactory Clavine Alkaloids Schizaphis Ergodesit Sklerofibrat Hemangioma, Capillary Amides Traumatic Cerebellar Hemorrhage rab3A GTP Binding Protein Cystatin Related Proteins Enoyl-(Acyl-Carrier-Protein) Reductase (NADH) Shockwaves, Ultrasonic Lipid Droplet Coat Proteins Screening Assays, High-Throughput Clavicles Carboxymethyl Cellulose Trauma Severity Index c-Ha-ras Genes Inhibitory Receptor, Killer Rifedot Interleukin-9 Immunoproteins Position Weight Matrices RFX1 Transcription Factor Micro-Health Insurance Animal Eliminative Behaviors Colocynth Uveomeningoencephalitides Protein, Nuclear Radiographic Kymography

Professional Narrative

Dr. Zefia Uppal was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Uppal has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.

Employment

Assistant Professor, Harvard Med 2019
Executive Director, Harvard Med 2000

Education

Doctor of osteopathic medicine, Baylor College 1998
Bachelor of science in nursing, Baylor College 2012

Referees

Publications

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :

Languages

Language Proficiency :

Translation Services :

Serving Millions of physicians and biomedical scientists in Industry and academia.

Site
Services
Follow Us
Contact Us
  • support@scienceandminds.com

Copyright © 2025 Trialect Inc. All rights reserved. | v2023.06.17.02